Product Information
LIKMEZ 500 MG/5 ML SUSPENSION is a brand product labeled by Saptalis Pharmaceuticals LLC, priced at $2.6012 per ML under NDC 71656006675. Its NADAC has been published 50 times since Oct 22, 2025.
FDA first approved this application on Sep 22, 2023.
Strength
100 mg/mL
Manufacturer
Saptalis Pharmaceuticals LLCNDC
71656006675
Classification
Brand
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METRONIDAZOLEApproval Type
New Drug (NDA)
FDA Application
NDA216755FDA Approved
9/22/2023
On Market Since
10/13/2023
Pharmacological Classes
Price Statistics
The NADAC for LIKMEZ 500 MG/5 ML SUSPENSION has been published 50 times since Oct 22, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.6012 per ML |
|---|---|
| All-time high | $2.6057 (Mar 11, 2026) |
| All-time low | $2.5879 (Nov 19, 2025) |
| 52-week high | $2.6057 |
| 52-week low | $2.5879 |
| Median price | $2.6001 |
| Average price | $2.5981 |
| Largest weekly change | +0.5% (Feb 18, 2026) |
| Weeks tracked | 50 |
| Tracking since | Oct 22, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Saptalis Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Metronidazole Oral market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nitroimidazole Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIKMEZ 500 MG/5 ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for LIKMEZ 500 MG/5 ML SUSPENSION, manufactured by Saptalis Pharmaceuticals LLC, is $2.6012 per ML (NDC 71656006675), effective Sep 30, 2026.
How has the price of LIKMEZ 500 MG/5 ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for LIKMEZ 500 MG/5 ML SUSPENSION has held within roughly two percent of its current level. It has been tracked across 50 weekly CMS publications since Oct 22, 2025.
What are the highest and lowest recorded NADAC prices for LIKMEZ 500 MG/5 ML SUSPENSION?
Since Oct 22, 2025, the NADAC for LIKMEZ 500 MG/5 ML SUSPENSION has ranged from a low of $2.5879 (Nov 19, 2025) to a high of $2.6057 (Mar 11, 2026), with a median of $2.6001 per ML.
Are there cheaper alternatives to LIKMEZ 500 MG/5 ML SUSPENSION?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LIKMEZ 500 MG/5 ML SUSPENSION in a comparable dosage form, but none are currently priced below it.
Who manufactures LIKMEZ 500 MG/5 ML SUSPENSION?
LIKMEZ 500 MG/5 ML SUSPENSION (NDC 71656006675) is labeled by Saptalis Pharmaceuticals LLC, and CMS classifies it as a brand product.